Foundation Medicine Inc (FMI.OQ)

FMI.OQ on NASDAQ Stock Exchange Global Select Market

48.11USD
4:00pm EDT
Change (% chg)

$-0.59 (-1.21%)
Prev Close
$48.70
Open
$48.37
Day's High
$48.37
Day's Low
$47.71
Volume
63,256
Avg. Vol
--
52-wk High
--
52-wk Low
--

FMI.OQ

Chart for FMI.OQ

About

Foundation Medicine, Inc. is a commercial-stage company. The Company is focused on fundamentally changing the way patients with cancer are treated. The Company’s platform includes methods and algorithms for analyzing tumor tissue samples across all types of cancer, as well as information aggregation and concise reporting... (more)

Overall

Beta: --
Market Cap(Mil.): $1,418.73
Shares Outstanding(Mil.): 29.13
Dividend: --
Yield (%): --

Financials

  FMI.OQ Industry Sector
P/E (TTM): -- 136.15 41.01
EPS (TTM): -1.87 -- --
ROI: -44.07 -0.91 16.17
ROE: -47.94 -2.73 17.02
Search Stocks

Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts

ZURICH/LOS ANGELES - Roche Holding will acquire a majority stake in molecular and genomic analysis business Foundation Medicine, it said on Monday, signaling its determination to expand in cancer immunotherapy by paying a hefty mark-up on the U.S. company's current price. | Video

12 Jan 2015

US STOCKS-Wall Street falls as oil prices drag

* Indexes off: Dow 0.46 pct, S&P 0.71 pct, Nasdaq 0.69 pct (Updates to late morning)

12 Jan 2015

US STOCKS-Wall Street falls as oil prices weigh on energy sector

* Indexes off: Dow 0.49 pct, S&P 0.55 pct, Nasdaq 0.41 pct (Updates to market open)

12 Jan 2015

US STOCKS-Wall Street set to open flat ahead of earnings

* Futures up: Dow 27 pts, S&P 2.75 pts, Nasdaq 8 pts (Adds quote, updates prices)

12 Jan 2015

US STOCKS-Futures advance ahead of earnings after two-week drop

* Futures up: Dow 56 pts, S&P 14.25 pts, Nasdaq 7.25 pts (Adds premarket actives)

12 Jan 2015

US STOCKS-Futures climb after two-week drop

NEW YORK, Jan 12 - U.S. stock index futures rose on Monday, after a two-day decline pushed the S&P 500 back into negative territory for the year, as investors anticipated the start of the corporate earnings season.

12 Jan 2015

UPDATE 2-Roche in $1 bln-plus Foundation Medicine deal to boost cancer efforts

* Drugmaker could invest another $150 mln in research funding

12 Jan 2015

Roche to buy majority stake in Foundation Medicine

Jan 12 - Swiss drug maker Roche Holding AG plans to acquire a majority stake in U.S.-based molecular and genomic analysis firm Foundation Medicine Inc by buying a combination of outstanding and newly issued shares, the companies said on Monday.

12 Jan 2015

Google to offer Foundation Medicine's cancer tests as latest health benefit

SAN FRANCISCO - Google will soon start covering the cost of Foundation Medicine's DNA tests for employees and their family-members suffering from cancer, as part of its health benefits portfolio.

05 Nov 2014

Google to offer Foundation Medicine's cancer tests as latest health benefit

SAN FRANCISCO, Nov 5 - Google will soon start covering the cost of Foundation Medicine's DNA tests for employees and their family-members suffering from cancer, as part of its health benefits portfolio.

05 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks